Omar Abdel‐Wahab

53.1k total citations · 7 hit papers
306 papers, 18.6k citations indexed

About

Omar Abdel‐Wahab is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Omar Abdel‐Wahab has authored 306 papers receiving a total of 18.6k indexed citations (citations by other indexed papers that have themselves been cited), including 185 papers in Molecular Biology, 139 papers in Hematology and 97 papers in Genetics. Recurrent topics in Omar Abdel‐Wahab's work include Acute Myeloid Leukemia Research (124 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (65 papers) and RNA Research and Splicing (46 papers). Omar Abdel‐Wahab is often cited by papers focused on Acute Myeloid Leukemia Research (124 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (65 papers) and RNA Research and Splicing (46 papers). Omar Abdel‐Wahab collaborates with scholars based in United States, France and Israel. Omar Abdel‐Wahab's co-authors include Ross L. Levine, Stanley Chun-Wei Lee, Craig B. Thompson, Patrick S. Ward, Jay P. Patel, Robert K. Bradley, Hagop M. Kantarjian, Jay Patel, Benjamin L. Ebert and María E. Figueroa and has published in prestigious journals such as Nature, New England Journal of Medicine and Cell.

In The Last Decade

Omar Abdel‐Wahab

290 papers receiving 18.4k citations

Hit Papers

The Common Feature of Leu... 2010 2026 2015 2020 2010 2012 2011 2012 2012 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate
    2010 1.5k citations Jay Patel, Omar Abdel‐Wahab et al. profile →
  2. IDH mutation impairs histone demethylation and results in a block to cell differentiation
    2012 1.5k citations Omar Abdel‐Wahab, Ross L. Levine et al. Nature profile →
  3. Clinical Effect of Point Mutations in Myelodysplastic Syndromes
    2011 1.1k citations Rafael Bejar, Kristen E. Stevenson et al. profile →
  4. Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis
    2012 577 citations Agnès Viale, Adriana Heguy et al. profile →
  5. The role of mutations in epigenetic regulators in myeloid malignancies
    2012 518 citations Omar Abdel‐Wahab, Ross L. Levine et al. profile →
  6. RNA splicing factors as oncoproteins and tumour suppressors
    2016 475 citations Eun Hee Kim, Omar Abdel‐Wahab et al. profile →
  7. Therapeutic targeting of splicing in cancer
    2016 395 citations Stanley Chun-Wei Lee, Omar Abdel‐Wahab profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Omar Abdel‐Wahab United States 68 10.9k 7.4k 5.3k 3.7k 2.2k 306 18.6k
D. Gary Gilliland United States 62 8.4k 0.8× 8.1k 1.1× 4.2k 0.8× 1.7k 0.4× 2.8k 1.3× 126 16.2k
D. Gary Gilliland United States 76 12.2k 1.1× 12.2k 1.7× 9.6k 1.8× 1.6k 0.4× 3.6k 1.6× 144 22.5k
Alan F. List United States 68 8.3k 0.8× 15.4k 2.1× 6.5k 1.2× 1.2k 0.3× 4.2k 1.9× 621 21.9k
Martin Carroll United States 49 6.8k 0.6× 4.7k 0.6× 2.1k 0.4× 2.3k 0.6× 2.6k 1.2× 200 11.7k
Maher Albitar United States 65 7.5k 0.7× 9.2k 1.2× 8.2k 1.5× 1.5k 0.4× 4.5k 2.1× 342 20.0k
Rajyalakshmi Luthra United States 65 5.0k 0.5× 4.1k 0.6× 3.6k 0.7× 3.8k 1.0× 3.6k 1.7× 308 13.7k
Rafaël Fonseca United States 84 16.2k 1.5× 17.5k 2.4× 5.8k 1.1× 1.3k 0.3× 9.9k 4.6× 441 25.8k
Oliver G. Ottmann Germany 62 4.9k 0.5× 10.4k 1.4× 5.0k 0.9× 748 0.2× 4.0k 1.8× 372 16.1k
Stephen D. Nimer United States 64 7.5k 0.7× 6.8k 0.9× 2.8k 0.5× 1000 0.3× 3.4k 1.6× 239 14.6k
Gautam Borthakur United States 65 6.7k 0.6× 13.2k 1.8× 6.5k 1.2× 947 0.3× 2.9k 1.3× 809 17.7k

Countries citing papers authored by Omar Abdel‐Wahab

Since Specialization
Citations

This map shows the geographic impact of Omar Abdel‐Wahab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Omar Abdel‐Wahab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Omar Abdel‐Wahab more than expected).

Fields of papers citing papers by Omar Abdel‐Wahab

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Omar Abdel‐Wahab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Omar Abdel‐Wahab. The network helps show where Omar Abdel‐Wahab may publish in the future.

Co-authorship network of co-authors of Omar Abdel‐Wahab

This figure shows the co-authorship network connecting the top 25 collaborators of Omar Abdel‐Wahab. A scholar is included among the top collaborators of Omar Abdel‐Wahab based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Omar Abdel‐Wahab. Omar Abdel‐Wahab is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wheeler, Emily C., Benjamín Martín, Melanie Donahue, et al.. (2024). Splicing modulators impair DNA damage response and induce killing of cohesin-mutant MDS and AML. Science Translational Medicine. 16(728). eade2774–eade2774. 17 indexed citations
2.
Benbarche, Salima, Bo Liu, Jeetayu Biswas, et al.. (2023). Synthetic Introns Identify the Novel RNA Splicing Factor GPATCH8 As Required for Mis-Splicing Induced By SF3B1 Mutations. Blood. 142(Supplement 1). 3–3. 1 indexed citations
3.
Ceglia, Nicholas, Jean-Benoît Le Luduec, Andrew McPherson, et al.. (2023). Immune profiling after allogeneic hematopoietic cell transplantation in pediatric acute myeloid leukemia. Blood Advances. 7(17). 5069–5081. 5 indexed citations
4.
Wang, Eric, et al.. (2023). Abstract A04: Modulation of RNA splicing enhances response to BCL2 inhibition in leukemia. Blood Cancer Discovery. 4(3_Supplement). A04–A04. 1 indexed citations
5.
Kfoury, Youmna, Fei Ji, Esha Jain, et al.. (2023). The bone marrow stroma in human myelodysplastic syndrome reveals alterations that regulate disease progression. Blood Advances. 7(21). 6608–6623. 7 indexed citations
6.
Ganzel, Chezi, Zhuoxin Sun, Timour Baslan, et al.. (2022). Measurable residual disease by flow cytometry in acute myeloid leukemia is prognostic, independent of genomic profiling. Leukemia Research. 123. 106971–106971. 5 indexed citations
7.
Stahl, Maximilian, Kamal Menghrajani, Andriy Derkach, et al.. (2021). Clinical and molecular predictors of response and survival following venetoclax therapy in relapsed/refractory AML. Blood Advances. 5(5). 1552–1564. 108 indexed citations
8.
Liu, Zhaoqi, Akihide Yoshimi, Jiguang Wang, et al.. (2020). Mutations in the RNA Splicing Factor SF3B1 Promote Tumorigenesis through MYC Stabilization. Cancer Discovery. 10(6). 806–821. 70 indexed citations
9.
Pangallo, Joseph, Jean‐Jacques Kiladjian, Bruno Cassinat, et al.. (2020). Rare and private spliceosomal gene mutations drive partial, complete, and dual phenocopies of hotspot alterations. Blood. 135(13). 1032–1043. 11 indexed citations
10.
Cohen‐Aubart, Fleur, Damien Roos‐Weil, Marine Armand, et al.. (2020). High frequency of clonal hematopoiesis in Erdheim-Chester disease. Blood. 137(4). 485–492. 36 indexed citations
11.
Gao, Yijun, Matthew T. Chang, Daniel J. McKay, et al.. (2018). Allele-Specific Mechanisms of Activation of MEK1 Mutants Determine Their Properties. Cancer Discovery. 8(5). 648–661. 87 indexed citations
12.
Spiciarich, David R., Stephen T. Oh, Michael J. Mauro, et al.. (2018). A Novel Germline Variant in CSF3R Reduces N-Glycosylation and Exerts Potent Oncogenic Effects in Leukemia. Cancer Research. 78(24). 6762–6770. 16 indexed citations
13.
Diamond, Eli L., Benjamin H. Durham, Ahmet Doǧan, et al.. (2017). Phase 2 Trial of Single-Agent Cobimetinib for Adults with BRAF V600-Mutant and Wild-Type Histiocytic Disorders. Blood. 130. 257–257. 3 indexed citations
14.
Zarnegar, Sara, Benjamin H. Durham, Pallavi Khattar, et al.. (2017). Novel activating BRAF fusion identifies a recurrent alternative mechanism for ERK activation in pediatric Langerhans cell histiocytosis. Pediatric Blood & Cancer. 65(1). 17 indexed citations
15.
Hyman, David M., Eli L. Diamond, Cecile Rose T. Vibat, et al.. (2014). Prospective Blinded Study of BRAF V600E Mutation Detection in Cell-Free DNA of Patients with Systemic Histiocytic Disorders. Cancer Discovery. 5(1). 64–71. 84 indexed citations
16.
Guzmán, Mónica L., Neng Yang, Krishan K. Sharma, et al.. (2014). Selective Activity of the Histone Deacetylase Inhibitor AR-42 against Leukemia Stem Cells: A Novel Potential Strategy in Acute Myelogenous Leukemia. Molecular Cancer Therapeutics. 13(8). 1979–1990. 45 indexed citations
17.
Abdel‐Wahab, Omar, Virginia M. Klimek, Agnès Viale, et al.. (2014). Efficacy of Intermittent Combined RAF and MEK Inhibition in a Patient with Concurrent BRAF- and NRAS-Mutant Malignancies. Cancer Discovery. 4(5). 538–545. 59 indexed citations
18.
Bejar, Rafael, Kristen E. Stevenson, Bennett Adam Caughey, et al.. (2012). Validation of a Prognostic Model and the Impact of Mutations in Patients With Lower-Risk Myelodysplastic Syndromes. Journal of Clinical Oncology. 30(27). 3376–3382. 312 indexed citations
19.
Klinakis, Apostolos, Camille Lobry, Omar Abdel‐Wahab, et al.. (2011). A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia. Nature. 473(7346). 230–233. 271 indexed citations
20.
Abdel‐Wahab, Omar, Taghi Manshouri, Jay Patel, et al.. (2010). Genetic Analysis of Transforming Events That Convert Chronic Myeloproliferative Neoplasms to Leukemias. Cancer Research. 70(2). 447–452. 227 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. Gary Gilliland Breakdown of academic impact, for papers by D. Gary Gilliland Breakdown of academic impact, for papers by Alan F. List Breakdown of academic impact, for papers by Martin Carroll Breakdown of academic impact, for papers by Maher Albitar Breakdown of academic impact, for papers by Rajyalakshmi Luthra Breakdown of academic impact, for papers by Rafaël Fonseca Breakdown of academic impact, for papers by Oliver G. Ottmann Breakdown of academic impact, for papers by Stephen D. Nimer Breakdown of academic impact, for papers by Gautam Borthakur
Rankless by CCL
2026